Zhang Luxia, Wang Jinwei, Yang Chih-Wei, Tang Sydney Chi-Wai, Kashihara Naoki, Kim Yong-Soo, Togtokh Ariunaa, Saad Syed, Ye Feng, Khan Maryam, Zaidi Deenaz, Osman Mohamed A, Lunney Meaghan, Okpechi Ikechi G, Jha Vivekanand, Harris David C H, Levin Adeera, Tonelli Marcello, Johnson David W, Bello Aminu K, Zhao Ming-Hui
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Peking University Institute of Nephrology, Peking University, Beijing, China.
Kidney Int Suppl (2011). 2021 May;11(2):e77-e85. doi: 10.1016/j.kisu.2021.01.011. Epub 2021 Apr 12.
Kidney failure (KF) is a public health problem in all regions of the world. We aim to provide comprehensive information regarding the disease burden of KF and capacity for providing optimal care in the International Society of Nephrology North and East Asia region based on data from the International Society of Nephrology Global Kidney Health Atlas project. Seven of eight jurisdictions participated, and wide variation was found in terms of KF burden and care capacity. Prevalence of long-term dialysis ranged from 88.4 per million population in mainland China to 3251 per million population in Taiwan. Hemodialysis was the predominant modality of dialysis in all jurisdictions, except for Hong Kong, where peritoneal dialysis (PD) was much more prevalent than hemodialysis. All jurisdictions provided public funding for kidney replacement therapy (dialysis and transplantation). Although the frequency and duration of hemodialysis followed a standard pattern in all investigated jurisdictions, the density of nephrologists and kidney replacement therapy centers varied according to income level. Conservative care, whether medically advised or chosen by patients, was available in most jurisdictions. All jurisdictions had official registries for KF and recognized KF as a health priority. These comprehensive data provide information about the burden of KF and capacity to provide optimal care in North and East Asia, which varied greatly across jurisdictions in the region.
肾衰竭是全球所有地区都面临的一个公共卫生问题。我们旨在根据国际肾脏病学会全球肾脏健康地图项目的数据，提供有关国际肾脏病学会北亚和东亚地区肾衰竭疾病负担以及提供最佳治疗能力的全面信息。八个司法管辖区中有七个参与了调查，结果发现肾衰竭负担和治疗能力存在很大差异。长期透析的患病率从中国大陆的每百万人口88.4例到台湾的每百万人口3251例不等。除香港外，血液透析是所有司法管辖区透析的主要方式，在香港，腹膜透析比血液透析更为普遍。所有司法管辖区都为肾脏替代治疗（透析和移植）提供公共资金。尽管在所有调查的司法管辖区中，血液透析的频率和时长遵循标准模式，但肾病专家的密度和肾脏替代治疗中心的数量因收入水平而异。在大多数司法管辖区，无论是医生建议还是患者选择，都可以获得保守治疗。所有司法管辖区都设有肾衰竭官方登记处，并将肾衰竭视为卫生工作的重点。这些全面的数据提供了有关北亚和东亚地区肾衰竭负担以及提供最佳治疗能力的信息，该地区各司法管辖区之间存在很大差异。
